Multimodality treatment of rectal cancer – Cancer Centre, Gliwice branch experience

Andrzej Chmielarz; Ewa Chmielnik; Grzegorz Plewicki; Grzegorz Słomian; Maciej Wideł; Magdalena Lasek-Kryj; Marcin Zeman; Mariusz Kryj; Rafał Suwiński

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

5/2003
vol. 7

Send email

Copy url:

abstract:

Multimodality treatment of rectal cancer – Cancer Centre, Gliwice branch experience

Andrzej Chmielarz

,

Ewa Chmielnik

,

Grzegorz Plewicki

,

Grzegorz Słomian

,

Maciej Wideł

,

Magdalena Lasek-Kryj

,

Marcin Zeman

,

Mariusz Kryj

,

Rafał Suwiński

Współcz Onkol (2003), vol. 7, 5, 346-353

Online publish date: 2004/01/28

View full text Get citation

A group of 132 cases (55 females and 77 males) of T_1-4N_0-+M_0-1 rectal cancer was subject to analysis. The average age was 62. The group of 75 patients was preoperatively irradiated using 4 different treatment schemes (25 Gy/5 Gy/fr, 42.5 Gy/1.8 Gy/fr, 30 gy/3 Gy/fr, 42 Gy/2 x 1.5 Gy/fr). All patients were treated surgically, abdomino-perineal resection (APR) was performed in 51 (43%) cases and low anterior resection (LAR) in 61 (52%), Hartman procedure was done in 3 (2%) and local excision in 2 (1.5%) cases. 15 (11%) patients were intraoperatively assessed as unresectable. Mean follow-up time was 12 months. 24-month disease-free survival (DFS) was 56.2% for the entire group, and was found to be significantly longer among patients who received preoperative radiotherapy: 63.9 vs. 36.2% (p=0.008). Local recurrence-free survival time was almost twice longer among irradiated patients (89% vs. 54%). No significant correlation was found between survival time and the preoperative treatment scheme. Of the entire group of patients, 31 (23%) of them developed distant metastases (DM) and 17 (13%) local recurrence (LR). LR rate was significantly higher in the non-irradiated group.
A remarkably downstaging effect was noticed in the irradiated group. Preoperative radiotherapy did not affect the possibility of performing sphincter saving procedures.
Preoperative radiotherapy is significantly influencing survival time and the risk of local failure. Effectiveness of different schemes of radiotherapy has to be assessed in prospective studies.

keywords:

Multimodality treatment of rectal cancer – Cancer Centre, Gliwice branch experience

Andrzej Chmielarz , Ewa Chmielnik , Grzegorz Plewicki , Grzegorz Słomian , Maciej Wideł , Magdalena Lasek-Kryj , Marcin Zeman , Mariusz Kryj , Rafał Suwiński

rectal cancer, radiotherapy, local recurrence, distant metastases

Andrzej Chmielarz

,

Ewa Chmielnik

,

Grzegorz Plewicki

,

Grzegorz Słomian

,

Maciej Wideł

,

Magdalena Lasek-Kryj

,

Marcin Zeman

,

Mariusz Kryj

,

Rafał Suwiński